A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers

PLoS ONE - United States
doi 10.1371/journal.pone.0040157
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Associations Between Selected Biomarkers and Prognosis in a Population-Based Pancreatic Cancer Tissue Microarray

Cancer Research
Cancer ResearchOncology
2009English

Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer

PLoS ONE
Multidisciplinary
2012English

Salivary HOTAIR and PVT1 as Novel Biomarkers for Early Pancreatic Cancer

Oncotarget
Oncology
2016English

Strategies for Discovering Novel Pancreatic Cancer Biomarkers

Journal of Proteomics
BiochemistryBiophysics
2013English

Noncoding RNAs as Novel Biomarkers in Pancreatic Cancer: What Do We Know?

Future Oncology
MedicineCancer ResearchOncology
2017English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

Tissue Microarray Is Suitable for Scientific Biomarkers Studies in Endometrial Cancer

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2018English

Analysis of the Expression of Biomarkers in Urinary Bladder Cancer Using a Tissue Microarray

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2008English

Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer

Journal of Cancer
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy